• LAST PRICE
    3.4300
  • TODAY'S CHANGE (%)
    Trending Down-0.1500 (-4.1899%)
  • Bid / Lots
    3.3900/ 2
  • Ask / Lots
    3.4500/ 11
  • Open / Previous Close
    3.5000 / 3.5800
  • Day Range
    Low 3.3600
    High 3.5000
  • 52 Week Range
    Low 1.3200
    High 12.4900
  • Volume
    350,173
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.58
TimeVolumeAEMD
09:32 ET238603.375
09:34 ET203343.37
09:36 ET18003.4
09:38 ET64603.375
09:39 ET20393.37
09:41 ET110263.3706
09:43 ET5813.3974
09:45 ET21543.4
09:48 ET7373.41
09:50 ET11243.4099
09:52 ET18713.4
09:54 ET21203.4085
09:56 ET82003.4
09:57 ET19003.4027
09:59 ET47843.4
10:01 ET31303.47
10:03 ET122833.39
10:08 ET4003.4001
10:10 ET43003.4
10:12 ET3003.41
10:14 ET2003.4073
10:19 ET27203.42
10:24 ET6203.4127
10:26 ET2003.425
10:28 ET12693.4499
10:30 ET52493.47
10:32 ET9863.45
10:33 ET9003.46
10:35 ET5003.4599
10:37 ET16003.45
10:39 ET5133.46
10:42 ET33853.4101
10:44 ET66843.4105
10:46 ET3003.415
10:48 ET2003.42
10:50 ET3003.42
10:51 ET31003.41
10:55 ET126513.39
11:00 ET3003.4
11:02 ET4083.4104
11:04 ET100003.4
11:06 ET2003.4016
11:08 ET17623.425
11:11 ET20933.45
11:13 ET27683.44
11:15 ET2003.43
11:22 ET12603.41
11:24 ET19823.4
11:26 ET5003.3929
11:27 ET192393.37
11:29 ET18213.3827
11:33 ET9393.4
11:36 ET6003.38
11:38 ET2003.375
11:40 ET2003.38
11:44 ET45003.38
11:45 ET52503.3773
11:47 ET16003.37
11:49 ET50123.38
11:51 ET3003.379
11:56 ET65983.37
11:58 ET3003.39
12:00 ET2053.4
12:03 ET13983.3999
12:05 ET23503.39
12:18 ET1003.3943
12:20 ET3003.405
12:30 ET3003.41
12:32 ET8003.43
12:34 ET38503.415
12:45 ET3003.41
12:50 ET30593.4
12:52 ET44673.3701
12:54 ET40063.38
12:56 ET18193.385
01:01 ET10003.3899
01:10 ET1073.3823
01:12 ET30003.4
01:15 ET1003.4
01:17 ET1503.3993
01:19 ET1003.4
01:26 ET21473.3887
01:28 ET17303.37
01:30 ET111833.365
01:33 ET30003.37
01:44 ET5003.3799
01:48 ET26003.3799
01:50 ET6503.36
01:53 ET4003.38
01:55 ET6003.375
02:02 ET2003.37
02:04 ET7003.37
02:09 ET9443.38
02:31 ET10003.4
02:44 ET2003.4
02:49 ET1003.416
02:51 ET5003.4161
02:54 ET6003.4001
02:56 ET10003.42
03:00 ET10003.41
03:03 ET4003.41
03:07 ET4003.405
03:09 ET15273.39
03:12 ET2003.38
03:14 ET1003.39
03:18 ET26903.36
03:21 ET4413.3689
03:23 ET3003.37
03:27 ET7003.39
03:32 ET26003.3884
03:34 ET6003.39
03:36 ET10003.3801
03:38 ET12003.395
03:39 ET2003.395
03:41 ET10003.3901
03:45 ET1003.395
03:50 ET23823.39
03:54 ET8833.395
03:56 ET102413.4
03:57 ET56003.4198
03:59 ET25873.43
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAEMD
Aethlon Medical Inc
52.8M
-5.1x
---
United StatesDXR
Daxor Corp
42.7M
134.5x
---
United StatesSQL
SeqLL Inc
41.6M
-12.4x
---
United StatesCSOC
Caduceus Software Systems Corp
42.1M
-136.9x
---
United StatesNMTC
Neuroone Medical Technologies Corp
46.5M
-3.7x
---
United StatesRSLS
ReShape Lifesciences Inc
43.7M
-1.3x
---
As of 2021-10-23

Company Information

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.

Contact Information

Headquarters
11555 SORRENTO VALLEY ROAD, SUITE 203SAN DIEGO, CA, United States 92121
Phone
858-459-7800
Fax
---

Executives

Chairman of the Board
Edward Broenniman
Chief Executive Officer
Charles Fisher
Chief Financial Officer, Senior Vice President - Finance, Secretary
James Frakes
Senior Vice President, Chief Business Officer
Guy Cipriani
Chief Medical Officer
Steven Larosa

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$52.8M
Revenue (TTM)
$791.1K
Shares Outstanding
15.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.49
EPS
$-0.67
Book Value
$0.78
P/E Ratio
-5.1x
Price/Sales (TTM)
66.7
Price/Cash Flow (TTM)
---
Operating Margin
-1,084.33%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.